Concepedia

Author

Vinay K. Billa

Icahn School of Medicine at Mount Sinai

Also Known As

Vinay K. Billa

5

Publications

231

Citations

4

H-Index

8

Concepts

All Affiliations

Icahn School of Medicine at Mount SinaiOnconova Therapeutics (United States)
VK

About

Vinay K. Billa is an author at Icahn School of Medicine at Mount Sinai specializing in drug discovery, pharmacotherapy, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

137

2

Natural Sciences

2

2

137

3

Biochemistry

2

2

137

4

Pharmacology

2

2

137

5

Drug Development

1

1

113

Vinay K. Billa

×

4

Publications

231

Citations

4

H-Index

YearCitations

Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors

M. V. Ramana Reddy, Vinay K. Billa, Venkat R. Pallela,

Bioorganic & Medicinal Chemistry

2008

113

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-<i>d</i>]pyrimidine-6-carbonitrile (<b>7x</b>) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)

M. V. Ramana Reddy, Balireddy Akula, Stephen C. Cosenza,

Journal of Medicinal Chemistry

2014

70

Design, Synthesis, and Biological Evaluation of (<i>E</i>)-<i>N</i>-Aryl-2-arylethenesulfonamide Analogues as Potent and Orally Bioavailable Microtubule-Targeted Anticancer Agents

M. V. Ramana Reddy, Muralidhar R. Mallireddigari, Venkat R. Pallela,

Journal of Medicinal Chemistry

2013

24

Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)

M. V. Ramana Reddy, Balireddy Akula, Shashi Jatiani,

Bioorganic & Medicinal Chemistry

2015

24

Page 1